Perioperative blood transfusion in major abdominal cancer surgery: a multi-centre service evaluation and national survey.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Abstract
In this prospective cohort study, data were collected on 412 patients undergoing surgery for intrabdominal malignancy in 14 NHS hospitals. Twenty-two (5.2%) patients received preoperative, 42 (10.2%) intraoperative, and 52 (12.2%) postoperative red blood cell transfusion. The mean postoperative transfusion trigger was 75.3 g L-1, and the mean number of units of red blood cells transfused was 1.5 (standard deviation, 1.1). Seventeen (4.0%) patients had a documented postoperative troponin elevation. Five (1.2%) patients died within 30 days of surgery. In the survey, 117 clinicians submitted complete responses, of whom 62 (53%) indicated that a transfusion threshold of 70 g L-1 was appropriate: however, this decreased to six (5.1%) if there was evidence of recent cardiac ischaemia. There were 100 (86%) respondents who indicated equipoise for a trial of restrictive vs liberal transfusion, decreasing to 56% if there was coexisting cardiovascular disease.Citation
McCullagh IJ, Begum S, Patel A, Gillies MA; UK Perioperative Medicine Clinical Trials Network Trial Development Group. Perioperative blood transfusion in major abdominal cancer surgery: a multi-centre service evaluation and national survey. BJA Open. 2022 Aug 23;3:100032. doi: 10.1016/j.bjao.2022.100032.Type
ArticleAdditional Links
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430868/PMID
37588576Journal
BJA OpenPublisher
Elsevierae974a485f413a2113503eed53cd6c53
10.1016/j.bjao.2022.100032